Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse

Neuromuscular Disorders

Volumn 7, Issue 1, 1997, Pages 7-12

  Matsumura, Kiichiro ^a   Yamada, Hiroki ^a   Saito, Fumiaki ^a   Sunada, Yoshihide ^a   Shimizu, Teruo ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Congenital muscular dystrophy; dy mouse; Dysmyelination; Dystroglycan; Merosin; 6 4 integrin

Indexed keywords

LAMININ;

ANIMAL MODEL; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; ENDONEURIUM; MOTOR NERVE; MOUSE; MUSCULAR DYSTROPHY; MYELIN DEFICIENCY; MYELIN SHEATH; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SCHWANN CELL; WHITE MATTER;

EID: 0030951457     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(96)00402-6     Document Type: Review

References (50)

1. [1] Arahata K, Hayashi YK, Koga R, et al. Laminin in animal models for muscular dystrophy: defect of laminin-M in skeletal and cardiac muscles and peripheral nerve of the homozygous dystrophic dy/dy mice. Proc Jpn Acad B 1993;69:259-64.
2. [2] Sunada Y, Bernier SM, Kozak CA, Yamada Y, Campbell KP. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin-M chain gene to dy locus. J Biol Chem 1994;269: 13729-32.
3. [3] Xu H, Christmas P, Wu XR, Wewer UM, Engvall E. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci USA 1994;91:5572-6.
4. [4] Tomé FMS, Evangelista T, Leclerc A, et al. Congenital muscular dystrophy with merosin deficiency. CR Acad Sci [III] 1994;371: 351-7.
5. [5] Hillaire D, Leclerc A, Fauré S, et al. Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet 1994;3:1657-61.
6. [6] Helbling-Leclerc A, Zhang X, Topaloglu H, et al. Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995;11:216-8.
7. [7] Philpot J, Sewry C, Pencock J, Dubowitz V. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromusc Disord 1995;5:301-5.
8. [8] Sewry CA, Philpot J, Mahony D, Wilson LA, Muntoni F, Dubowitz V. Expression of laminin subunits in congenital muscular dystrophy. Neuromusc Disord 1995;5:307-16.
9. [9] Sunada Y, Edgar TS, Lotz BP, Rust RS, Campbell KP. Merosin-negative congenital muscular dystrophy associated with extensive brain abnormalities. Neurology 1995;45:2084-9.
10. [10] Hayashi YK, Koga R, Tsukahara T, et al. Deficiency of laminin α2-chain mRNA in muscle in a patient with merosin-negative congenital muscular dystrophy. Muscle Nerve 1995;18:1027-30.
11. [11] Mercuri E, Muntoni F, Berardinelli A, Pennock J, Sewry C, Dubowilz V. Somatosensory and visual evoked potentials in congenital muscular dystrophy: correlation with MRI changes and muscle merosin status. Neuropaediatrics 1995;26:3-7.
12. [12] Shorer Z, Philpot J, Muntoni F, Sewry C, Dubowitz V. Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy. J Child Neurol 1995;10:472-5.
13. [13] Bradley WG, Jaros E. Involvement of peripheral and central nerves in murine dystrophy. NY Acad Sci 1979;317:132-42.
14. [14] Tinsley JM, Blake DJ, Zuellig RA, Davies KE. Increasing complexity of the dystrophin-associated protein complex. Proc Natl Acad Sci USA 1994;91:8307-13.
15. [15] Campbell KP. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 1995;80:675-9.
16. [16] Ozawa E, Yoshida M, Suzuki A, Mizuno Y, Hagiwara Y, Noguchi S. Dystrophin-associated proteins in muscular dystrophy. Hum Mol Genet 1995;4:1711-6.
17. [17] Worton R. Muscular dystrophies: diseases of the dystrophin-glycoprotein complex. Science 1995;270:755-6.
18. [18] Passos-Bueno MR, Moreira ES, Vainzof M, Zatz M. Linkage analysis in autosomal recessive limb-girdle muscular dystrophy (AR LGMD) maps a sixth form to 5q33-34 (LGMD2F) and indicates that there is at least one more subtype of AR LGMD Hum Mol Genet 1996;5:815-20.
19. [19] Nigro V, Piluso G, Belsito A, et al. Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. Hum Mol Genet 1996;5:1179-86.
20. [20] Jung D, Duclos F, Apostol B, et al. δ-Sarcoglycan: a novel 35 kDa component of the sarcoglycan complex is involved in autosomal recessive muscular dystrophy linked to 5q33-q34. J Biol Chem, in press.
21. [21] Ervasti JM, Campbell KP. Membrane organization of the dystrophin-glycoprotein complex. Cell 1991;66:1121-31.
22. [22] Ibraghimov-Beskrovnaya O, Ervasti JM, Levcille CJ. Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 1992;355:696-702.
23. [23] Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993;122:809-23.
24. [24] Suzuki A, Yoshida M, Hayashi K, Mizuno Y, Hagiwara Y, Ozawa E. Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin. Eur J Biochem 1994;220:283-92.
25. [25] Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP. Identification and characterization of the dystrophin anchoring site on β-dystroglycan. J Biol Chem 1995;270:27305-10.
26. [26] Burgeson RE, Chiquet M, Deutzmann R, et al. A new nomenclature for the laminins. Matrix Biol 1994;14:209-11.
27. [27] Leivo I, Engvall E, Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc Nat Acad Sci USA 1988;85:1544-8.
28. [28] Sanes JR, Engvall E, Butkowski R, Hunter DD. Molecular heterogeneity of basal laminae. Isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J Cell Biol 1990;111:1685-99.
29. [29] Gee SH, Blacher RW, Douville PJ, Provost PR, Yurchenco PD, Carbonetto S. Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J Biol Chem 1993;268:14972-80.
30. [30] Xu H, Wu X-R, Wewer UM, Engvall E. Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene. Nat Genet 1994;8:297-302.
31. 2J mice. Hum Mol Genet 1995;4:1055-61.
32. [32] Madrid RE, Jaros E, Cullen MJ, Bradley WG. Genetically determined defect of Schwann cell basement membrane in dystrophic mouse. Nature 1975;257:319-21.
33. [33] Jaros E, Jenkinson M. Quantitative studies of the abnormal axon-Schwann cell relationship in the peripheral motor and sensory nerves of the dystrophic mouse. Brain Res 1983;258: 181-96.
34. [34] Rasminsky M, Kearney R, Aguayo AJ, et al. Conduction of nervous impulses in spinal roots and peripheral nerves of dystrophic mouse. Brain Res 1978;143:71-85.
35. [35] Huizar P, Kuno M, Miyata Y. Electrophysiological properties of spinal motoneurones of normal and dystrophic mice. J Physiol (London) 1975;248:231-46.
36. [36] Yamada H, Shimizu T, Tanaka T, Campbell KP, Matsumura K. Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett 1994;352:49-53.
37. [37] Yamada H, Chiba A, Endo T, et al. Characterization of dystroglycan-laminin interaction in peripheral nerve. J Neurochem 1996;66:1518-24.
38. [38] Byers TJ, Lidov HGW, Kunkel LM. An alternative dystrophin transcript specific to peripheral nerve. Nat Genet 1993;4:77-81.
39. [39] Schachner M, Martini R. Glycans and the modulation of neural-recognition molecule function. Trends Neurosci 1995;18:183-91.
40. [40] Ruegg MA, Tsim KWK, Horton S, et al. The agrin gene codes for a family of basal lamina proteins that differ in function and distribution. Neuron 1992;8:691-9.
41. [41] Yamada H, Denzer AJ, Hori H, et al. Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane. J Biol Chem 1996;271:23418-23.
42. [42] Fallon JR, Hall ZW. Building synapses: agrin and dystroglycan stick together. Trends Neurosci 1994;17:469-473.
43. [43] Carbonetto S, Lindenbaum M. The basement membrane at the neuromuscular junction: a synaptic mediatrix. Curr Opin Neurobiol 1995;5:596-605.
44. [44] Yang B, Jung D, Motto D, Meyer J, Koretzky G, Campbell KP. SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem 1995;270:11711-4.
45. [45] Giancotti FG. Signal transduction by the α6β4 integrin: charting the path between laminin binding and nuclear events. J Cell Sci 1996;109:1165-72.
46. [46] Einheber S, Milner TA, Giancotti F, Salzer JM. Axonal regulation of Schwann cell integrin expression suggests a role for α6β4 in myelination. J Cell Biol 1993;123:1223-36.
47. [47] Feltri ML, Scherer SS, Nemni R, et al. β4 integrin expression in myelinating Schwann cells is polarized, developmentally regulated and axonally dependent. Development 1994;120:1287-301.
48. [48] Eldridge CF, Bunge MB, Bunge RP. Defferentiation of axon-related Schwann cells in vitro: II. control of myelin formation by basal lamina. J Neurosci 1989;9:625-38.
49. [49] Anton ES, Sandrock AWJ, Mathew WD. Merosin promotes neurite growth and Schwann cell migration in vitro and nerve regeneration in vivo: evidence using an antibody to merosin, ARM-1. Dev Biol 1994;164:133-46.
50. [50] Obremski VJ, Bunge MB. Addition of purified basal lamina molecules enables Schwann cell ensheathment of sympathetic neuntes in culture. Dev Biol 1995;168:124-37.